Take a look at the Recent articles

Introduction

Parkinson’s Disease, PD, is regarded as a serious neurodegenerative disorder caused by degeneration of dopamine neurons [1], affecting many regions of the nervous system [2]. It affects 0.3% of the world's general population and the incidence rate is about 1% in people over 60 years of age and 4-5% in the population aged between 85 years or older [3]. This disease causes motor dysfunction, cognitive, autonomic and mental dysfunction [4]. It is obviously that life quality is seriously decreased [3]. Bradykinesia, rigidity and tremor are dominant three main signs in PD [5]. These manifestations were associated with drooling, dysphagia, xerostomia and periodontal disease [6].

Oral symptoms in PD

The dominant manifestations of oral symptom in PD presents salivary excretion, swallowing difficulties, dry mouth, tongue diseases [7], periodontitis and tooth decay [8].

Firstly, the drooling is an universal phenomenon of excessive accumulation and overflow of saliva inside the oral cavity [9] in PD patients, which affects their diet, speech and social interaction with others [10]. The prevalence of drooling in PD is 10%~81% [11]. Furthermore, there is a positive correlation between increasing drooling and accelerating dysphagia [12,13].

Secondly, the PD patients are reporting stiffness in oropharyngeal muscles [14], which may lead to dysphagia. Accompanied with decreased swallowing, their oropharyngeal secretions are accumulating. This is the key factor causing the infection of oral secretions and increasing the possibility of risk of developing aspiration pneumonia [12,13].

Thirdly, periodontitis has been often a symptom by PD patients [15]. The decreased amount of saliva flow in PD patients may be leading to a weak oral cleaning ability [16]. Moreover, the deficit of motor and cognitive control, their oral health hygiene level is extremely low [17]. Interestingly, Chen CK, et al. reported that the patients with periodontitis have a higher risk of developing a PD [18]. Periodontal disease can be a leading factor to increase systemic inflammatory mediators [17], which then destructs the blood-brain barrier [18]. Consequently, lipopolysaccharide (LPS) produced from periodontal microbes may be a dominant factor in the development and progression of PD [6]. Therefore, it is of great significance to strengthen the education on good oral hygiene habits to prevent Parkinson's disease by reducing inflammation [18].

Fourthly, salivary secretion has been decreased in PD patients. Consequently, this reduces the ability of oral hygiene and bacteriostasis. The weak oral clearance and poor periodontal health may be more progressive in the later stage [19].

Relationship between oral flora and symptoms

Both, Gram-positive and negative bacteria are increased in the oral cavity of PD patients [20]. Pereira, et al. in 2017 reports that there was a difference in beta diversity and abundance of individual bacterial groups between the PD patients and control group [21]. Interestingly, the number of Porphyromonas gingivalis and mutant cocci have increased. Furthermore, opportunistic oral pathogens including Veillonella, Prevotella, Prevotellaceae, Corobacter, Lactobacillaceae, and Iaceae in PD were increased, however, the kingella, caphocytophaga, Rothia, Leptotrichiaceae and Actinomyces decreased respectively [22].

The presence of gram-negative bacteria in PD patients was identified which is the dominant factor for periodontal disease [23]. Due to dystonia in PD patients, the accumulation of oral saliva was increased [24]. As a result of aggravating saliva flow instability, saliva inhibition activity disappeared; the microbial community was transferred to Gram-negative bacteria accordingly [25]. Furthermore, Michelle A, et al. reported that there were more Streptococcus mutant in the oral cavity of patients with PD [26]. These bacteria were dominant leading to the decayed tooth [27,28].

Prospective

Long time neuroinflammation process may accelerate the progress of central nervous disease. Therefore, it is important to keep oral clean.

Acknowledgement

This work was supported by Sichuan Provincial Education Department (18ZB0156), and Chengdu Medical College Natural Science Foundation (CYZ18-20, CYZ18-33).

References

1. Béné R, Antić S, Budisić M, Lisak M, Trkanjec Z, et al. (2009) Parkinson's disease. Acta Clin Croat 48: 377-380. [Crossref]
2. O'Callaghan C, Lewis SJG (2017) Cognition in Parkinson's Disease. Int Rev Neurobiol 133: 557-583. [Crossref]
3. Lew M (2007) Overview of Parkinson's disease. Pharmacotherapy 27: 155S-160S. [Crossref]
4. Williams-Gray CH, Foltynie T, Lewis SJ, Barker RA (2006) Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options. CNS Drugs 20: 477-505. [Crossref]
5. Tysnes OB, Storstein A (2017) Epidemiology of Parkinson's disease. J Neural Transm (Vienna) 124: 901-905. [Crossref]
6. Chen CK, Wu YT, Chang YC (2017) Periodontal inflammatory disease is associated with the risk of Parkinson's disease: a population-based retrospective matched-cohort study. PeerJ 5: e3647. [Crossref]
7. Barbe AG, Ludwar L, Scharfenberg I, Hellmich M, Dano R, et al. (2018) Circadian rhythms and influencing factors of xerostomia among Parkinson's disease patients. Oral Dis 2018: 1-5. [Crossref]  
8. Van Stiphout MAE, Marinus J, van Hilten JJ, Lobbezoo F, de Baat C, et al. (2018) Oral Health of Parkinson's Disease Patients: A Case-Control Study. Parkinsons Dis 2018: 9315285. [Crossref]
9. Srivanitchapoom P, Pandey S, Hallett M (2014) Drooling in Parkinson's disease: a review. Parkinsonism Relat Disord 20: 1109-1118. [Crossref]
10. Wi GR, Moon BI, Kim HJ, Lim W, Lee A, et al. (2016) A lectin-based approach to detecting carcinogenesis in breast tissue. Oncol Lett 11: 3889-3895. [Crossref]
11. Mao CJ, Xiong YT, Wang F, Yang YP, Yuan W et al. (2018) Motor subtypes and other risk factors associated with drooling in Parkinson's disease patients. Acta Neurol Scand 137: 509-514. [Crossref]
12. Nobrega AC, Rodrigues B, Torres AC, Scarpel RD, Neves CA, et al. (2008) Is drooling secondary to a swallowing disorder in patients with Parkinson's disease? Parkinsonism Relat Disord 14: 243-245. [Crossref]
13. Karakoc M, Yon MI, Cakmakli GY, Ulusoy EK, Gulunay A, et al. (2016) Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia. Neurol Sci 37: 1987-1991. [Crossref]
14. Stetten de W (1913) V. Angulation of the Junction of the Hepatic and Common Ducts after Cholecystostomy, Simulating Common Duct Obstruction. Ann Surg 57: 182-187. [Crossref]
15. Hanaoka A, Kashihara K (2009) Increased frequencies of caries, periodontal disease and tooth loss in patients with Parkinson's disease. J Clin Neurosci 16: 1279-1282. [Crossref]
16. Müller T1, Palluch R, Jackowski J (2011) Caries and periodontal disease in patients with Parkinson's disease. Spec Care Dentist 31: 178-181. [Crossref]
17. Kaur T1, Uppoor A2, Naik D1 (2016) Parkinson's disease and periodontitis - the missing link? A review. Gerodontology 33: 434-438. [Crossref]
18. Chen CK, Huang JY, Wu YT, Chang YC, et al. (2018) Dental Scaling Decreases the Risk of Parkinson's Disease: A Nationwide Population-Based Nested Case-Control Study. Int J Environ Res Public Health 15. [Crossref]
19. Bakke M1, Larsen SL, Lautrup C, Karlsborg M (2011) Orofacial function and oral health in patients with Parkinson's disease. Eur J Oral Sci 119: 27-32. [Crossref]
20. Gosney M1, Punekar S, Playfer JR, Bilsborrow PK, Martin MV (2003) The incidence of oral Gram-negative bacteria in patients with Parkinson's disease. Eur J Intern Med 14: 484-487. [Crossref]
21. Kodukula K1,2,3, Faller DV4,5, et al. (2017) Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. Biores Open Access 6: 123-132. [Crossref]
22. Gondim Teixeira PA, Savi de Tové KM, Abou Arab W, Raymond A, Louis M. et al., Erratum to “Subchondral linear hyperintensity of the femoral head: MR imaging findings and associations with femoro-acetabular joint pathology”. Diagn Interv Imaging 2017. 98: 367. [Crossref]
23. Nagle RE, Low-Beer T, Horton R (1989) Diltiazem and heart block. Lancet 1: 907. [Crossref]
24. Tiigimae-Saar J, Tamme T, Rosenthal M, Kadastik-Eerme L, Taba P, et al. (2018) Saliva changes in Parkinson's disease patients after injection of Botulinum neurotoxin type A. Neurol Sci. 39: 871-877. [Crossref]  
25. Barbe AG, Deutscher DHC, Derman SHM, Hellmich M, Noack MJ, et al. (2017) Subjective and objective halitosis among patients with Parkinson's disease. Gerodontology 34: 460-468. [Crossref]
26. Kennedy MA1, Rosen S, Paulson GW, Jolly DE, Beck FM (1994) Relationship of oral microflora with oral health status in Parkinson's disease. Spec Care Dentist 14: 164-168. [Crossref]
27. Chen H, Jiang W (2014) Application of high-throughput sequencing in understanding human oral microbiome related with health and disease. Front Microbiol 5: 508. [Crossref]
28. Costalonga M1, Herzberg MC2 (2014) The oral microbiome and the immunobiology of periodontal disease and caries. Immunol Lett 162: 22-38. [Crossref]